SEC Comment Letter for BioCardia, Inc. (BCDA) (CIK 0000925741) (BCDA) — Feb 20, 2020
BioCardia, Inc. (BCDA) (CIK 0000925741)
Date: Feb. 20, 2020 · CIK: 0000925741 · Accession: 0000000000-20-001547
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-236404
Letter
February 19, 2020 Peter Altman, Ph.D. Chief Executive Officer BioCardia, Inc. 125 Shoreway Road, Suite B San Carlos, CA 94070 Re:BioCardia, Inc. Registration Statement on Form S-1 Filed February 13, 2020 File No. 333-236404 Dear Dr. Altman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Michael J. Danaher, Esq.
Show Raw Text
February 19, 2020
Peter Altman, Ph.D.
Chief Executive Officer
BioCardia, Inc.
125 Shoreway Road, Suite B
San Carlos, CA 94070
Re:BioCardia, Inc.
Registration Statement on Form S-1
Filed February 13, 2020
File No. 333-236404
Dear Dr. Altman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Michael J. Danaher, Esq.